Cetera Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $6.58M | Buy |
723,490
+676,963
| +1,455% | +$6.16M | 0.05% | 365 |
|
|
2023
Q4 | $208K | Sell |
46,527
-4,935
| -10% | -$22K | ﹤0.01% | 1621 |
|
|
2023
Q3 | $162K | Sell |
51,462
-1,370
| -3% | -$4.3K | ﹤0.01% | 1565 |
|
|
2023
Q2 | $273K | Sell |
52,832
-2,073
| -4% | -$10.7K | ﹤0.01% | 1355 |
|
|
2023
Q1 | $289K | Buy |
54,905
+1,958
| +4% | +$10.3K | ﹤0.01% | 1303 |
|
|
2022
Q4 | $149K | Buy |
52,947
+1,285
| +2% | +$3.61K | ﹤0.01% | 1475 |
|
|
2022
Q3 | $214K | Buy |
51,662
+2,078
| +4% | +$8.61K | 0.01% | 1106 |
|
|
2022
Q2 | $199K | Buy |
49,584
+2,040
| +4% | +$8.19K | ﹤0.01% | 1246 |
|
|
2022
Q1 | $235K | Buy |
47,544
+4,391
| +10% | +$21.7K | ﹤0.01% | 1231 |
|
|
2021
Q4 | $301K | Sell |
43,153
-43,763
| -50% | -$305K | 0.01% | 1117 |
|
|
2021
Q3 | $869K | Buy |
+86,916
| New | +$869K | 0.02% | 663 |
|